Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies.

MLA

de Groot, Fleur A., et al. “Clinical Characteristics and Survival Outcomes of Patients with Primary Central Nervous System Lymphoma Treated with High-Dose Methotrexate-Based Polychemotherapy and Consolidation Therapies.” European Journal of Cancer (Oxford, England : 1990), vol. 213, Oct. 2024, p. 115068. EBSCOhost, https://doi.org/10.1016/j.ejca.2024.115068.

APA

de Groot, F. A., Dekker, T. J. A., Doorduijn, J. K., Böhringer, S., Brink, M., de Groen, R. A. L., de Haan, L. M., Woei-A-Jin, F. J. S. H., Noordenbos, T., Sijs-Szabo, A., Oudshoorn, M. A., Lam, K. H., Diepstra, A., Te Boome, L. C. J., Terpstra, V., Bohmer, L. H., Nicolae, A., Posthuma, E. F. M., Koens, L., … Vermaat, J. S. P. (2024). Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies. European Journal of Cancer (Oxford, England : 1990), 213, 115068. https://doi.org/10.1016/j.ejca.2024.115068

Chicago

de Groot, Fleur A, Tim J A Dekker, Jeanette K Doorduijn, Stefan Böhringer, Mirian Brink, Ruben A L de Groen, Lorraine M de Haan, et al. 2024. “Clinical Characteristics and Survival Outcomes of Patients with Primary Central Nervous System Lymphoma Treated with High-Dose Methotrexate-Based Polychemotherapy and Consolidation Therapies.” European Journal of Cancer (Oxford, England : 1990) 213 (October): 115068. doi:10.1016/j.ejca.2024.115068.